Unrecognized indication for aortic valve neocuspidization: Patient with warfarin-induced Stevens–Johnson syndrome and toxic epidermal necrolysis
Journal of Cardiac Surgery, cilt.37, sa.6, ss.1733-1735, 2022 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 37 Sayı: 6
- Basım Tarihi: 2022
- Doi Numarası: 10.1111/jocs.16404
- Dergi Adı: Journal of Cardiac Surgery
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, CINAHL, EMBASE, MEDLINE
- Sayfa Sayıları: ss.1733-1735
- Anahtar Kelimeler: aortic valve neocuspidization, Stevens-Johnson syndrome, toxic epidermal necrolysis, warfarin
- Sağlık Bilimleri Üniversitesi Adresli: Evet
Özet
Stevens–Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are severe disorders, characterized by necrosis and epidermal detachment. Most important known acquired etiological factor is medications. Warfarin is one of the most common medications of cardiac valve surgery, which may rarely cause SJS or TEN. From this perspective, Aortic Valve Neocuspidization (AVNeo) procedure may be a good treatment option for such kind of patients, with a unique advantage of anticoagulation free postoperative course. In this report we aimed to share a patient with warfarin-induced STS/TEN, who was successfully treated with AVNeo procedure and mitral valve replacement.